DK277187A - Farmaceutisk komposition omfattende et ikke-toksisk, inert, farmaceutisk acceptabelt, vandigt baerermedium og en tumornekrosefaktor samt fremgangsmaade til fremstilling af kompositionen. - Google Patents
Farmaceutisk komposition omfattende et ikke-toksisk, inert, farmaceutisk acceptabelt, vandigt baerermedium og en tumornekrosefaktor samt fremgangsmaade til fremstilling af kompositionen.Info
- Publication number
- DK277187A DK277187A DK277187A DK277187A DK277187A DK 277187 A DK277187 A DK 277187A DK 277187 A DK277187 A DK 277187A DK 277187 A DK277187 A DK 277187A DK 277187 A DK277187 A DK 277187A
- Authority
- DK
- Denmark
- Prior art keywords
- water
- pharmaceutical composition
- carriing
- toxic
- inert
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 2
- 201000011510 cancer Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 231100000252 nontoxic Toxicity 0.000 title 1
- 230000003000 nontoxic effect Effects 0.000 title 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 229920001583 poly(oxyethylated polyols) Polymers 0.000 abstract 1
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86876686A | 1986-05-29 | 1986-05-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK277187D0 DK277187D0 (da) | 1987-05-29 |
| DK277187A true DK277187A (da) | 1987-12-01 |
Family
ID=25352278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK277187A DK277187A (da) | 1986-05-29 | 1987-05-29 | Farmaceutisk komposition omfattende et ikke-toksisk, inert, farmaceutisk acceptabelt, vandigt baerermedium og en tumornekrosefaktor samt fremgangsmaade til fremstilling af kompositionen. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0247860B1 (da) |
| JP (1) | JPS62289522A (da) |
| AT (1) | ATE77959T1 (da) |
| AU (1) | AU595321B2 (da) |
| CA (1) | CA1283046C (da) |
| DE (1) | DE3780218T2 (da) |
| DK (1) | DK277187A (da) |
| FI (1) | FI872393L (da) |
| NO (1) | NO872227L (da) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5091176A (en) * | 1988-11-02 | 1992-02-25 | W. R. Grace & Co.-Conn. | Polymer-modified peptide drugs having enhanced biological and pharmacological activities |
| US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
| US5306500A (en) * | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
| US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
| US6166183A (en) * | 1992-11-30 | 2000-12-26 | Kirin-Amgen, Inc. | Chemically-modified G-CSF |
| WO1990006952A1 (fr) * | 1988-12-22 | 1990-06-28 | Kirin-Amgen, Inc. | Facteur de stimulation de colonies de granulocytes modifies chimiquement |
| EP0460101A4 (en) * | 1989-02-24 | 1992-04-15 | Immunotherapeutics, Inc. | Immobilized cytokines |
| US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
| DK0393438T3 (da) | 1989-04-21 | 2005-05-30 | Amgen Inc | TNF-receptor, TNF-bindende proteiner og DNAér, der koder herfor |
| US6221675B1 (en) | 1989-04-21 | 2001-04-24 | Amgen, Inc. | TNF receptors, TNF binding proteins and DNAs coding for them |
| US7264944B1 (en) | 1989-04-21 | 2007-09-04 | Amgen Inc. | TNF receptors, TNF binding proteins and DNAs coding for them |
| IL95031A (en) | 1989-07-18 | 2007-03-08 | Amgen Inc | Method for the production of a human recombinant tumor necrosis factor inhibitor |
| US6143866A (en) * | 1989-07-18 | 2000-11-07 | Amgen, Inc. | Tumor necrosis factor (TNF) inhibitor and method for obtaining the same |
| DK0437563T3 (da) * | 1989-08-07 | 1995-05-29 | Debio Rech Pharma Sa | Bioligiske aktive lægemiddelpolymerderivater |
| DE3936777A1 (de) * | 1989-11-04 | 1991-05-08 | Basf Ag | Quervernetzte tumor-nekrose-faktoren |
| JPH04218000A (ja) * | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
| US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| WO1992006995A1 (en) * | 1990-10-18 | 1992-04-30 | Board Of Regents, The University Of Texas System | Preparation and characterization of liposomal formulations of tumor necrosis factor |
| US5653974A (en) * | 1990-10-18 | 1997-08-05 | Board Of Regents,The University Of Texas System | Preparation and characterization of liposomal formulations of tumor necrosis factor |
| ES2145744T5 (es) * | 1991-01-18 | 2008-02-01 | Amgen Inc. | Procedimientos para tratar las enfermedades inducidas por el factor de necrosis tumoral. |
| AU3423293A (en) * | 1991-12-19 | 1993-07-19 | Baylor College Of Medicine | Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US5629384A (en) * | 1994-05-17 | 1997-05-13 | Consiglio Nazionale Delle Ricerche | Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces |
| US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| TW555765B (en) | 1996-07-09 | 2003-10-01 | Amgen Inc | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins |
| IT1291114B1 (it) | 1997-03-20 | 1998-12-29 | Angeletti P Ist Richerche Bio | Varianti del fattore neurotrofico ciliare (cntf) con migliorata selettivita' al recettore, e metodo per la loro selezione |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| DE10144252A1 (de) | 2001-08-31 | 2003-03-27 | Fraunhofer Ges Forschung | Nanopartikel mit daran immobilisiertem biologisch aktivem TNF |
| US7179891B2 (en) | 2002-03-25 | 2007-02-20 | Tadanori Mayumi | Physiologically active complex |
| JP4177604B2 (ja) * | 2002-03-25 | 2008-11-05 | 株式会社林原生物化学研究所 | 生理活性複合体 |
| TW200526780A (en) | 2004-01-06 | 2005-08-16 | Hayashibara Biochem Lab | TNF antagonists and TNF inhibitors comprising the same as the active ingredient |
| US20070065514A1 (en) * | 2005-09-22 | 2007-03-22 | Howell Mark D | Method for enhancing immune responses in mammals |
| CN101219219B (zh) * | 2007-01-10 | 2013-02-13 | 北京普罗吉生物科技发展有限公司 | 包含血管抑素或其片段的复合物、其制备方法及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4414147A (en) * | 1981-04-17 | 1983-11-08 | Massachusetts Institute Of Technology | Methods of decreasing the hydrophobicity of fibroblast and other interferons |
| DE3380726D1 (en) * | 1982-06-24 | 1989-11-23 | Japan Chem Res | Long-acting composition |
| DE3572982D1 (en) * | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
| AU580431B2 (en) * | 1985-06-26 | 1989-01-12 | Cetus Corp | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| JP2524586B2 (ja) * | 1985-06-26 | 1996-08-14 | シタス コーポレイション | ポリマ−接合を利用する医薬組成物用蛋白質の可溶化 |
-
1987
- 1987-03-26 CA CA000533061A patent/CA1283046C/en not_active Expired - Fee Related
- 1987-05-27 DE DE8787304703T patent/DE3780218T2/de not_active Expired - Lifetime
- 1987-05-27 NO NO872227A patent/NO872227L/no unknown
- 1987-05-27 AT AT87304703T patent/ATE77959T1/de not_active IP Right Cessation
- 1987-05-27 EP EP87304703A patent/EP0247860B1/en not_active Expired - Lifetime
- 1987-05-28 FI FI872393A patent/FI872393L/fi not_active IP Right Cessation
- 1987-05-28 AU AU73479/87A patent/AU595321B2/en not_active Ceased
- 1987-05-29 DK DK277187A patent/DK277187A/da not_active Application Discontinuation
- 1987-05-29 JP JP62131911A patent/JPS62289522A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE3780218T2 (de) | 1992-12-17 |
| EP0247860A2 (en) | 1987-12-02 |
| AU7347987A (en) | 1987-12-03 |
| FI872393A0 (fi) | 1987-05-28 |
| ATE77959T1 (de) | 1992-07-15 |
| AU595321B2 (en) | 1990-03-29 |
| DK277187D0 (da) | 1987-05-29 |
| JPS62289522A (ja) | 1987-12-16 |
| EP0247860B1 (en) | 1992-07-08 |
| FI872393A7 (fi) | 1987-11-30 |
| EP0247860A3 (en) | 1989-10-11 |
| FI872393L (fi) | 1987-11-30 |
| NO872227L (no) | 1987-11-30 |
| CA1283046C (en) | 1991-04-16 |
| DE3780218D1 (de) | 1992-08-13 |
| NO872227D0 (no) | 1987-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK277187A (da) | Farmaceutisk komposition omfattende et ikke-toksisk, inert, farmaceutisk acceptabelt, vandigt baerermedium og en tumornekrosefaktor samt fremgangsmaade til fremstilling af kompositionen. | |
| MX174442B (es) | Composiciones farmaceuticas y procedimiento para prepararlas | |
| ATE101035T1 (de) | Implantierbares, biologisch abbaubares wirkstofffreigabesystem. | |
| FI885109A0 (fi) | Foerfarande foer solidifikation och inkapsling med anvaendning av kaern-skalpolymerpartiklar. | |
| EP0169443A3 (en) | Tricyclic dihydropyridazinones and pharmaceutical compositions contaning them | |
| FR2377381A1 (fr) | Derives de piperidine et leur utilisation comme stabilisants de polymeres | |
| DE68914304D1 (de) | Härtbare Polymerzusammensetzung. | |
| ATE146676T1 (de) | Transdermales therapeutisches system für broncholytika | |
| DE69003466D1 (de) | Substituierte Thienopyrimidin-Derivate, deren Herstellung, pharmazeutische Zusammensetzungen und medizinische Verwendung. | |
| DK0384416T3 (da) | Farmaceutisk sammensætning indeholdende hydantoinderivat | |
| DE68913798D1 (de) | Härtbare Polymerzusammensetzung. | |
| ES2051864T3 (es) | Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer. | |
| FR2652266B1 (fr) | Vaccin protecteur contre l'hemophilose porcine. | |
| JPS56155286A (en) | Water-absorbing agent composition for soil | |
| IL74692A0 (en) | Pharmaceutical compositions comprising 4,9-dihydro-4(1-methyl-4-piperidinylidene)-10h-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one and a biodegradable polymer | |
| IT8025473A0 (it) | Derivati piridossinici ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche. | |
| FR2616326B1 (fr) | Compositions therapeutiques a base de nouveaux aminoacylates d'acetal du glycerol | |
| ITMI932377A0 (it) | Composizioni terapeutiche ad attivita' antitumorale a base di derivati 1,3,8,10 tetrasostituiti del 4,5,6,7-tetratiocino (1,2-b: 3,4-b') diimidazolil-2,9 ditione | |
| FI844438A7 (fi) | Stroemningsdriven maetapparat. | |
| IT1230571B (it) | Procedimento per la preparazione di formulazioni antiacido ad azione protratta e formulazioni cosi'ottenute. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |